Portfolio Companies
|
 |
| ExThera Medical Corporation is developing an affinity therapy for removing pathogens and cytokines from blood for the treatment of sepsis and other infectious diseases as well as blood purification. |
 |
 |
| Biomimedica, Inc Boimimedica, which is incubating on our premises, is developing a polymer technology for replacing the damaged articular cartilage surface of joints. The company has completed Series A funding. |
 |
|
| COR Innovations, Inc COR Innovations is developing solutions to prevent heart failure after an acute myocardial infarction. |